EKSO | tickerfilter.com

Fundamental analysis

54%

Profitability 50%

Dept financing 48%

Liquidity 75%

Performance 55%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

18.26%

1 Month

26.18%

3 Months

-17.97%

6 Months

-47.04%

1 Year

-60.58%

2 Year

-64.44%

Key data

Stock price

$0.51

P/E Ratio

0.00

DAY RANGE

$0.44 - $0.51

EPS

-$0.56

52 WEEK RANGE

$0.34 - $1.53

52 WEEK CHANGE

-$58.99

MARKET CAP

13.419 M

YIELD

N/A

SHARES OUTSTANDING

18.444 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-28-2025

BETA

0.48

PUBLIC FLOAT

AVERAGE 10 VOLUME

$176,020

AVERAGE 30 VOLUME

$132,819

Company detail

CEO: Steven Sherman
Region: US
Website: eksobionics.com
Employees: 60
IPO year: 2014

Issue type: Common Stock
Market: XNAS
Industry: Machinery/General Industrial Machinery & Equipment
Sector: Manufacturing

Ekso Bionics Holdings, Inc. designs, develops, sells, rents, and rents exoskeleton products. EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury. The company has a license agreement with Lockheed Martin Corporation.

EKSO - EKSO BIONICS HOLDINGS, INC.